Heparin Inhibition of Endothelial Cell Proliferation and Organization is Dependent on Molecular Weight

  • Khorana A
  • Sahni A
  • Altland O
 et al. 
  • 52


    Mendeley users who have this article in their library.
  • 105


    Citations of this article.


OBJECTIVE: Studies have shown improved survival in cancer patients treated with low molecular weight heparins (LMWHs). Tumors depend on an expanding vasculature, and heparins may affect vessel growth and function. We investigated the effect of heparins differing in Mr on selected endothelial cell properties. METHODS AND RESULTS: Human umbilical vein endothelial cells were cultured with fibroblast growth factor-2 and heparins differing in Mr. Cell proliferation was assessed by [3H]thymidine incorporation, and vascular organization was assessed by in vitro assays. Maximum inhibition of 94+/-2% was observed with 6-kDa LMWH, greater than the inhibition seen with unfractionated heparin (58+/-8%) or 3-kDa LMWH (60+/-9%, P=0.02 for both). No inhibition of proliferation was observed with heparin tetrasaccharide, octasaccharide, or pentasaccharide (fondaparinux). Three- and 6-kDa fractions decreased endothelial tube formation in Matrigel to 58+/-15% and 67+/-9% (P8 saccharide units, with maximal inhibition at Mr of 6 kDa. This Mr dependence differs from that required for anticoagulant activity.

Author-supplied keywords

  • Angiogenesis
  • Cancer
  • Endothelium
  • Low molecular weight heparins
  • Thrombosis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Alok A. Khorana

  • Abha Sahni

  • Owen D. Altland

  • Charles W. Francis

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free